NVO•benzinga•
Novo Nordisk Rises 5% In Premarket As Analyst Dismisses Friday's 17% Plunge As Market Overreaction
Summary
Analysts at Intron Health, led by Naresh Chouhan, suggested that Friday's market reaction was excessively severe.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 23, 2024 by benzinga